Skip to content

A clinical trial of Siddha drugs M V kashayam (Internally) for the management and treatment of COVID 19

A prospective non randomized single arm, single center clinical study to evaluate the effectiveness of Siddha medicine M V Kashayam in the management and treatment of COVID 19 patients

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029289
Enrollment
130
Registered
2020-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: MV kashayam: The kashayam has prepared with multi herbs combination and study its efficacy in curing the COVID 19 patients at the dose rate of 150 ml for every six hours interval for 6

Sponsors

Arul Anandar College
Lead Sponsor
Indian Medicine and Homeopathy Department
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Patients with positive RT- PCR test 2. The age group of 15 yrs to 60 yrs. 3. Patients with mild and moderate symptoms of COVID 19. 4. Patients of both sex and willing to accept the treatment method. Withdrawal Criteria i) Intolerance to the drug and development of any serious adverse effect during a drug trial. ii) Poor patient compliance & defaulters iii) Patient is unwilling to continue the course of clinical Study. iv) The occurrence of any other systemic illness.

Exclusion criteria

Exclusion criteria: i.RT- PCR negative patients ii.Patients of less than 15 yrs and above 60 yrs of age. iii.Pregnant and breastfeeding women. iv.Patients with severe COVID 19 symptoms. v.Allopathic Antiviral treatment patients.

Design outcomes

Primary

MeasureTime frame
The medicine for Prophylactic and treatment of COVID 19 based on RT-PCR negative, CRPTimepoint: 12 weeks (3 months)

Secondary

MeasureTime frame
Get approved medicine for COVID 19Timepoint: 7 days to 14 days

Countries

India

Contacts

Public ContactDr P Dharumarajan

Government Hospital

harsanasiddhamm@gmail.com9442355686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026